Health
J&J, AstraZeneca explore COVID-19 vaccine modification after blood clot reports – WSJ – Financial Post
Johnson & Johnson and AstraZeneca are conducting early research into whether modifications to their COVID-19 vaccines could eliminate…
Johnson & Johnson and AstraZeneca are conducting early research into whether modifications to their COVID-19 vaccines could eliminate or reduce the risk of rare blood clots linked to the shots, the Wall Street Journal reported, citing people close to the…
Continue Reading
-
Noosa News19 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News17 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News18 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News18 hours agoGood character references restricted in rape cases in Queensland